Life Sciences

Enabling Value Based Care
Home Life Sciences

A fundamental shift in health benchmarks towards value-based care and patient-centricity has disrupted the Life Sciences industry. These increased expectations have eventually resulted in innovator companies reevaluating development programs, innovate business models, adopt new technologies, redefine reimbursement strategy and clinical pipeline approach. Accommodating these disruptions is challenging and that can be achieved through improved R&D productivity, accelerated R&D and product development, and building partnerships throughout the value chain.

FutureBridge enables these aspirations of Life Sciences innovators by providing actionable techno-commercial insights derived from its customized intelligence programs that are backed by scientific proof, sentiments of key opinion leaders, and voice of the industry.

Life SciencesDigitalization

Role of Open Innovation and Consortium in Accelerating Drug Discovery

In recent years major pharmaceutical companies have re-organized their R&D structure via M&A, external partnerships, out-sourcing and open innovation. Pharmaceutical companies have started adopting open innovation model for commercial success, due to the...

Life Sciences

Rare Cancers: Challenges and Roadmap for R&D Innovations

Drug development for Rare cancers is challenging because it is difficult to obtain relevant data from very few patients. The oncology community is increasingly facing a disproportionate fraction of the total burden of cancers, hence, requiring multi-stakeholder...

Blockchain in Electronic Health Records (EHR) – A Distant Future but a Step in a Right Direction

Life SciencesEvolving Ecosystems

In the healthcare industry, there are growing incidences of patient mortality due to the decisions made on fragmented & inaccessible...

Simplifying Cancer Detection using point-of-care Technologies

Life SciencesValue-Based Treatment

Current Scenario & Challenges in Cancer Detection Approximately 1 in 6 people die of cancer. Multiple factors are expected to fuel the...

Technology Landscape & Monitoring – Targeted Protein Degradation

Life Sciences

A multinational integrated biopharma multinational client had a strategic need to screen and achieve comprehensive assessments of Targeted...

Event Impact Analysis for Molecular Diagnostics

Life Sciences

The Client was interested to conduct a market assessment study to evaluate the market potential in the molecular diagnostic domain, with...

Regenerative Medicine – An off the Shelf Therapy Option

#upcoming webinar – 28 Sept’21

Regenerative medicines have produced new groundbreaking therapies in various dimensions of disease treatment primarily utilizing cell therapy, gene therapy, gene-modified cell therapy, and tissue engineering medicines.  However, the journey for Regenerative medicines is packed with challenges ranging from regulations, affordability, quality consistency, acceptance by the medical fraternity, and ethics pressure groups.

 

Regenerative Medicine – An off the Shelf Therapy Option

#upcomging webinar – 28 Sept’21

Regenerative medicines have produced new groundbreaking therapies in various dimensions of disease treatment primarily utilizing cell therapy, gene therapy, gene-modified cell therapy, and tissue engineering medicines. However, the journey for Regenerative medicines is packed with challenges ranging from regulations, affordability, quality consistency, acceptance by the medical fraternity, and ethics pressure groups.

Strategic Growth Fields

A convergence of industry transformations and exponential technologies creates a pool of opportunities

Paradigm Shift in
R&D

  • Shared risks & costs
  • Virtual clinical trials & remote R&D
  • Portfolio optimization & LCM
  • Naturals & Alternatives

Personalization &
Precision

  • Theragnostics
  • Gene & cell therapy
  • Targeted drug delivery
  • Minimally invasive surgery (MIS)

Preventive Care & Predictive Diagnostics

  • Prophylactic care & vaccination
  • Early screening & rapid diagnosis
  • Real-time monitoring & treatment
  • Therapeutic nutrition

Evolving
Ecosystem

  • Value-based care
  • Home care
  • Patient Centricity & patient partnership
  • Wellness & self-care
Exponential Digital Technologies
  • Sustainability 85% 85%
  • Digitalization 94% 94%
  • Business Model Innovation 87% 87%
  • Synthetic Biology 92% 92%
  • Big Data & Clinical Algorithms 85% 85%

Our Solutions

Our solutions combine a unique blend of research, consulting, and hyper-intelligence industry & technology platforms for deep insights
With our techno-commercial acumen, we unearth growth opportunities, connect technologies with markets and deliver business impact

test

Future of Life Sciences

icon Therapies
icon Technology Platforms
icon Markets
icon Disease Patterns
icon Competition
icon Regulation & Reimbursement

Future of Life Sciences

icon Therapies
icon Technology Platforms
icon Markets
icon Disease Patterns
icon Competition
icon Regulation & Reimbursement
Foresight & Weak Signals
Key Industry Trends & Exponential Technologies
Technology Landscape & Deep Dive
Markets & Regulations Assessment
Technology Roadmaps & Horizon Planning
Business Disruption Monitoring & Opportunity Radar
Solutions Scouting & Benchmarking
Technology, Market & Business Model Evaluation
Innovation Pipeline Development
Partner & Supplier Identification & Assessment
Business Continuity: Key Data, Competitive Positioning, and Customer Analysis
Partner/Supplier Collaboration & M&A Support
Technology Adoption
Technology Commercialization
Company / Technology Benchmarking & Due Diligence
Technology Implementation Ecosystems

The Business Functions for Whom We Create Value

Insights
Strategize
Implement Disruption
How can I be faster and more dynamic in product development?
How are gene therapy related devices are evolving?
Is it feasible to adapt MoAs from other therapy areas to our focus areas?
What are different Digital technologies for active patient engagement?
What are the unmet needs in existing product portfolio?
How can we prioritize the ongoing developments to be ahead in the competition in the Oncology?
What are the new regulations related to digital therapeutics?
What are new routes of drug delivery under clinical trials?
What are the technologies available to improve & measure efficacy of naturals for treatment?
What are future scenarios for my industry?
Early Signals
Landscape –Technology, Competition, Disease, Indications, Systems
Growth Opportunity identification – Drugs, Devices, Platforms, Markets, Products, Partnerships
Policy & Regulations
Success Case Studies & Evolving Business Models
Collaboration and M&A Support

Life science

Therapies

Technology Platforms

Markets

Disease Patterns

Competition

Regulation & Reimbursement

Short Term
Medium Term
Long Term

The Business Functions for Whom We Create Value

Diverse technological advancements will define the future of connected mobility

The Business Functions For Whom We Create Value

Diverse technological advancements will define future of connected mobility

  • Insights
  • Strategize
  • Implement Disruption
  • How can I be faster and more dynamic in product development?
  • How are gene therapy related devices are evolving?
  • Is it feasible to adapt MoAs from other therapy areas to our focus areas?
  • What are different Digital technologies for active patient engagement?
  • What are the unmet needs in existing product portfolio?
  • How can we prioritize the ongoing developments to be ahead in the competition in the Oncology?
  • What are new routes of drug delivery under clinical trials?
  • What are the technologies available to improve & measure efficacy of naturals for treatment?
  • What are future scenarios for my industry?
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Early Signals
  • Landscape –Technology, Competition, Disease, Indications, Systems
  • Growth Opportunity identification – Drugs, Devices, Platforms, Markets, Products, Partnerships
  • Policy & Regulations
  • Success Case Studies & Evolving Business Models
  • Collaboration and M&A Support
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • What novel combination therapies innovations will disrupt Oncology?
  • How are companies leveraging rare disease product development ?
  • What are advancements in digitization for R&D teams?
  • What are different drug repurposing routes companies opting?
  • What are innovations in personalized medicine mean with in allergy therapy area?
  • What areas to focus on during the product design stage to address any future regulatory concerns?
  • How are companies scanning Early innovation from academia?
  • Where are the innovation hot spots for enhancing patient experience?
  • Which start-ups can help me digitally transform drug dispensing experience?
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Clinical trial analytics and continuous monitoring
  • Competitive intelligence, assessment & benchmarking
  • Partner identification, selection and prioritization
  • Unmet need identification and new opportunity area
  • Trends, events & impact monitoring
  • Portfolio synergy building & matchmaking
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • How can I select most appropriate partner/acquisition?
  • What future portfolio needs will I have with changing patient dynamics?
  • How can I introduce new technology related to remote patient monitoring?
  • What are the upcoming solutions to predict clinical outcomes?
  • Which smartphone apps can enhance my existing portfolio?
  • What are strategies and productivity benchmarks of US based large size companies for “virtual clinical trials”?
  • How patient centric clinical trials and R&D would shape up in long term with EPR development ?
  • What are the KOLs perspective on adoption and safety of digital pill?
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Current and evolving patient journey
  • Comparison and landscape of clinical guidelines (Multiple countries)
  • Clinical outcome comparisons – Medicine/ Procedures/ Diagnosis
  • Digitalization and disease advocacy impact
  • Novel solution and innovation scouting
  • External innovation – Technology acquisition
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Which New digital technologies such as patient education and advocacy will
  • Where can I find new start-ups that can enable faster feedback loop?
  • How has Biomarker innovation disrupted prescription uptake ?
  • How supply chain disruptions are impacting the delivery of medical devices/technology?
  • Where will unmet needs be within medical affairs?
  • What are the key patient trends? Impact on my business?
  • How do I continuously track the start up innovation ecosystem in Pain segment ?
  • What technologies could be adopted from adjacent industries ?
  • How will regulations & reimbursement policies impact my market potential in the next 5years?
  • Short Term
  • Medium Term
  • Long Term
  • Insights
  • Strategize
  • Implement Disruption
  • Portfolio gap analysis & Geography market focus
  • Health technology assessment, medical affairs and source of business
  • Entry/Exit/Licensing (Geography/Markets/Therapies)
  • Market sizing - short & long term forecasting, event impact analysis
  • Regulatory & reimbursement scenario planning
  • New Entity/Product Acquisition
  • Short Term
  • Medium Term
  • Long Term

Client's Success Stories

Digital Solutions for Orthopedic Surgeries

Life SciencesDigitalization

Our client was working towards digitalizing the various aspects related to patient management for orthopedic surgeries. To...

Indication Prioritization & Opportunity Selection

Life Sciences

A leading European pharmaceutical company was interested in deep dive therapeutic area (TA) level analysis to analyze and...

New Feature

Login with your mobile number. Update now.